The genetic testing market has progressed substantially over the past years owing to major improvements in technologies, growing healthcare needs, and increased awareness. The market is majorly impacted by growing awareness and demand and improvements in technologies. There is a rising public awareness and growing interest in genetic testing, propelled by media coverage and educational campaigns for different health conditions common across the globe. Moreover, advancements in sequencing technologies like NGS (Next-Generation Sequencing) have notably improved genetic testing in terms of speed, accuracy, and cost-effectiveness. Nonetheless, the genetic testing market is hampered by ethical and privacy issues.
Global Genetic Testing Market size was valued at USD 8.0 billion in 2023 and is poised to grow from USD 9.84 billion in 2024 to USD 51.55 billion by 2032, growing at a CAGR of 23.0% during the forecast period (2025-2032).
Get Your Free Sample Report: https://www.skyquestt.com/sample-request/genetic-testing-market
Key Growth Drivers:
- Advancements in Sequencing Technologies: Innovations in sequencing methods have made genetic testing more accessible and cost-effective, facilitating its integration into mainstream healthcare.
- Rising Demand for Personalized Medicine: The increasing emphasis on tailored treatment strategies has amplified the need for genetic testing to inform clinical decisions.
- Growing Awareness and Aging Population: Enhanced public awareness and a rising elderly demographic contribute to the heightened demand for genetic diagnostics.
Regional Insights:
North America currently leads the market, driven by the adoption of personalized genetic testing services and the prevalence of chronic and genetic disorders. The U.S. Food and Drug Administration’s approval of new genetic tests further supports market expansion in the region.
Market Segmentation:
Global Genetic Testing Market is segmented by Technology, Application, Product, Channel, End Use and region.
- Based on Technology, the market is segmented into Next Generation Sequencing, Array Technology, PCR – based Testing, FISH and Others.
- Based on Application, the market is segmented into Ancestry & Ethnicity, Traits Screening, Genetic Disease Carrier Status, New Baby Screening and Health and Wellness – Predisposition/ Risk / Tendency.
- Based on Product, the market is segmented into Consumables, Equipment and Software & Services.
- Based on Channel, the market is segmented into Online and Offline. Based on End Use, the market is segmented into Hospitals & Clinics, Diagnostic Laboratories and Others.
- Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Leading Market Players:
- Illumina, Inc. (USA)
- Roche Holding AG (Switzerland)
- Thermo Fisher Scientific Inc. (USA)
- QIAGEN N.V. (Netherlands)
- Abbott Laboratories (USA)
- Agilent Technologies, Inc. (USA)
- Bio-Rad Laboratories, Inc. (USA)
- Danaher Corporation (USA)
- Myriad Genetics, Inc. (USA)
- 23andMe, Inc. (USA)
- Invitae Corporation (USA)
- Natera, Inc. (USA)
- NeoGenomics, Inc. (USA)
- Guardant Health, Inc. (USA)
- Siemens Healthineers AG (Germany)
- Hologic, Inc. (USA)
- BGI Genomics Co., Ltd. (China)
- Eurofins Scientific (Luxembourg)
- Adaptive Biotechnologies Corporation (USA)
These companies are at the forefront of genetic testing innovations, contributing to the market’s dynamic landscape.
Genetic Testing Key Market Trends
- Genetic Testing beyond DNA: Today, genetic testing is not just associated with examining DNA but goes beyond that. Genetic testing is expanding to comprise RNA and epigenetic alterations that do not change the DNA ‘code’, but impact how the code is understood and applied within human cells. This will not only improve genetic variation detection but also help understand these variants and their importance for an individual’s health.
Recent Developments
- In June 2024, Deep Genomics, a techbio company based in Toronto, recently unveiled its new laboratory and office in Cambridge, Massachusetts. This new office and lab will be an expansion of its office in Toronto and multiple leadership hires. They will work to create RNA therapies for genetic illnesses with ML.
- In July 2023, Quest Diagnostics, a diagnostic information services leader, introduced its 1st consumer-initiated genetic test, named Genetic Insights. The novel offering helps individuals understand possible risk of suffering from specific inheritable health disease with improved technology and end-to-end assistance comprising personalized health access and report to genetic counselling.
To access the full report, visit: https://www.skyquestt.com/report/genetic-testing-market
About Us:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Us:
SkyQuest Technology
1 Apache Way, Westford,
Massachusetts 01886
USA (+1) 351-333-4748
Email: [email protected]
